Latest
Structure Search
Popular Resources
Events & Community
Directories
Quick Search
Ctrl+
K
HIGHLIGHTS
PREMIUM
Apr. 18, 2023
Million-Dollar Molecules: A Dual TYK2/JAK1 Inhibitor Licensed to Biohaven, an Oral IRAK4 Degrader Exclusively Licensed by Gilead, a Ph. I AT2R Inhibitor Acquired by Eli Lilly, and more
Drug Hunter Team
Loading...
Other articles you may be interested in